Kevin Murphy, MD, is a board-certified radiation oncologist who specializes in treating tumors of the central nervous system (CNS), or brain and spinal cord. Dr. Murphy founded the Stereotactic Radiosurgery Program at UCSD in 2005. His expertise includes using novel technologies such as frameless stereotactic radiosurgery (SRS), intensity modulated stereotactic radiosurgery (IM-SRS) and hypo-fractionated stereotactic radiosurgery to treat brain tumors in both adults and children.
He received his bachelor’s in science from University of Notre Dame and a master’s in neurophysiology from Purdue University. He earned his medical degree from the University of Chicago Pritzker School of Medicine and completed his radiation oncology residency at University of Chicago School of Medicine.
Dr. Murphy has co-authored several book chapters and many abstracts and peer-reviewed articles. His work has appeared in the Journal of Neuro-Oncology, Translational Cancer Research, and Practical Radiation Oncology, among others. He is a frequent speaker at both national and international medical conferences, having over 100 invited lectures in 23 countries.
More recently, Dr. Murphy has gained wide expertise in the emerging field of repetitive transcranial magnetic stimulation (rTMS), and has created a proprietary, personalized approach to rTMS treatment termed PrTMS. Dr. Murphy uses his PrTMS approach to help people with neurocognitive disorders including veterans and athletes who have an interest in maintaining high-level human performance. Dr. Murphy also is working with DOD on the first clinical studies to formally assess the effect of PrTMS on sleep, focus, reaction time, and other human performance metrics.
Dr. Murphy is a proud US Navy veteran serving as an engineering officer aboard the aircraft carrier USS Ranger (CV 61) during Operations Desert Shield/Desert Storm.